Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1979 Dec;131(6):526-32.

Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero

R J Kurman

Symposium on Adolescent Gynecology and Endocrinology. Part II: Secondary amenorrhea, hirsutism in adolescents and the clinical consequences of stilbestrol exposure in utero. The clinical consequences of stilbestrol exposure in utero

R J Kurman. West J Med. 1979 Dec.

Abstract

PIP: The Registry of Clear Cell Adenocarcinoma of the Genital Tract in Young Women contains pathologic data on more than 300 women who were exposed to diethylstilbestrol (DES) in utero. The patients range in age from 7 to 29 years; most tumors appear from 14 to 23 years of age. Clear cell carcinoma is not the msot frequent sequela of maternal DES treatment; other, but benignant, sequelae may be vaginal adenosis, cervical ectropion, gross vaginal and cervical deformities, microglandular hyperplasia, and cervical or vaginal ridges. Alterations can be detected also in exposed males. The pathogenesis of DES related lesions is still not very clear. All women exposed to antenatal DES must be examined starting either at the time of menarche, or by age 14; examination should include visualization, palpation, and cytological tests. Approximately 1/4 of women with clear cell carcinoma of the vagina and cervix will not survive. Both radical surgical procedures and radiation have been used effectively; results with chemotherapy treatment have been disappointing.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. J Invest Dermatol. 1973 Jun;60(6):457-74 - PubMed
    1. Am J Obstet Gynecol. 1973 Jun 15;116(4):470-84 - PubMed
    1. Arch Dermatol Forsch. 1972;243(3):164-76 - PubMed
    1. Mayo Clin Proc. 1972 Sep;47(9):629-30 - PubMed
    1. Am J Obstet Gynecol. 1972 Feb 1;112(3):364-8 - PubMed

Substances

LinkOut - more resources